High proliferation index, as determined by immunohistochemical expression of Aurora kinase B and geminin, indicates poor prognosis in neuroblastomas
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High proliferation index, as determined by immunohistochemical expression of Aurora kinase B and geminin, indicates poor prognosis in neuroblastomas
Authors
Keywords
Neuroblastoma, Proliferation indices, Digital image analysis, Aurora kinase B, Geminin
Journal
VIRCHOWS ARCHIV
Volume 467, Issue 3, Pages 319-327
Publisher
Springer Nature
Online
2015-07-21
DOI
10.1007/s00428-015-1806-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Geminin loss causes neural tube defects through disrupted progenitor specification and neuronal differentiation
- (2014) Ethan S. Patterson et al. DEVELOPMENTAL BIOLOGY
- Aurora kinase A is superior to Ki67 as a prognostic indicator of survival in neuroblastoma
- (2014) Pramila Ramani et al. HISTOPATHOLOGY
- Aurora Kinases as Targets in Drug-Resistant Neuroblastoma Cells
- (2014) Martin Michaelis et al. PLoS One
- Cell cycle analysis can differentiate thin melanomas from dysplastic nevi and reveals accelerated replication in thick melanomas
- (2014) Gergo Kiszner et al. VIRCHOWS ARCHIV
- Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis
- (2013) Matthias May et al. BJU INTERNATIONAL
- Emerging Role of Geminin as a Prognostic Marker in Systemic Malignancies
- (2013) Shailendra Kapoor Journal of Breast Cancer
- Targeting nuclear kinases in cancer: Development of cell cycle kinase inhibitors
- (2013) Todd M. Pitts et al. PHARMACOLOGY & THERAPEUTICS
- Aurora-A controls pre-replicative complex assembly and DNA replication by stabilizing geminin in mitosis
- (2013) Takaaki Tsunematsu et al. Nature Communications
- Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
- (2012) G Schleiermacher et al. BRITISH JOURNAL OF CANCER
- High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer
- (2012) O.P. Erpolat et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Aurora B: A New Prognostic Marker and Therapeutic Target in Cancer
- (2011) G. Portella et al. CURRENT MEDICINAL CHEMISTRY
- Aurora B kinase expression in laryngeal squamous cell carcinoma and its prognostic implications
- (2011) Eugenia García-Fernández et al. HISTOPATHOLOGY
- The cell cycle and cancer
- (2011) Gareth H Williams et al. JOURNAL OF PATHOLOGY
- The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma In Vivo
- (2011) A. Faisal et al. MOLECULAR CANCER THERAPEUTICS
- System-Level Analysis of Neuroblastoma Tumor-Initiating Cells Implicates AURKB as a Novel Drug Target for Neuroblastoma
- (2010) O. Morozova et al. CLINICAL CANCER RESEARCH
- Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesis
- (2010) Derek M. Murphy et al. MOLECULAR CARCINOGENESIS
- Myc proteins as therapeutic targets
- (2010) W C Gustafson et al. ONCOGENE
- Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer
- (2009) M Loddo et al. BRITISH JOURNAL OF CANCER
- Nuclear Overexpression of Mitotic Regulatory Proteins in Biliary Tract Cancer: Correlation with Clinicopathologic Features and Patient Survival
- (2009) Y.-C. Shen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients
- (2009) Yi-Jen Chen et al. VIRCHOWS ARCHIV
- Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy
- (2008) S. Tanaka et al. BRITISH JOURNAL OF SURGERY
- Cdt1 and Geminin in cancer: markers or triggers of malignant transformation?
- (2008) Chariklia Petropoulou Frontiers in Bioscience-Landmark
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- Geminin is overexpressed in human pancreatic cancer and downregulated by the bioflavanoid apigenin in pancreatic cancer cell lines
- (2008) Mohammad R. Salabat et al. MOLECULAR CARCINOGENESIS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started